Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease

Journal of Cardiovascular Medicine

Volumn 9, Issue 12, 2008, Pages 1246-1253

  Sheiban, Imad ^a   Garrone, Paolo ^a   Sillano, Dario ^a   Biondi Zoccai, Giuseppe ^a   Sciuto, Filippo ^a   Omedè, Pierluigi ^a   Lombardi, Primiano ^a   Meliga, Emanuele ^a   Anselmino, Matteo ^a   Trevi, Gian Paolo ^a   Moretti, Claudio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Coronary artery disease; Diabetes mellitus; Left main; Percutaneous transluminal coronary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; INSULIN; ORAL ANTIDIABETIC AGENT; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITAL; HUMAN; IMPLANTATION; INSULIN DEPENDENT DIABETES MELLITUS; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; STENT THROMBOSIS; DEATH; DIABETES MELLITUS; HEART MUSCLE REVASCULARIZATION; TREATMENT OUTCOME;

AGED; CORONARY DISEASE; DEATH; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; TREATMENT OUTCOME;

EID: 59449107919     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32830d8303     Document Type: Article

References (23)

1. Briguori C, Colombo A, Airoldi F, Focaccio A, Iakovou I, Chieffo A, et al. Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease. Am Heart J 2005; 150:807-813.
2. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004; 109:2273-2278.
3. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolin R, et al., DIABETES Investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112:2175-2183.
4. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000; 35:1122-1129.
5. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al., Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115:2344-2351.
6. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241:2035-2038.
7. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053.
8. Dortimer AC, Shenoy PN, Shiroff RA, Leaman DM, Babb JD, Liedtke AJ, Zelis R. Diffuse coronary artery disease in diabetic patients: fact or fiction? Circulation 1978; 57:133-136.
9. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007; 49:1600-1606.
10. Holmes DR Jr, Kim LJ, Brooks MM, Kip KE, Schaff HV, Detre KM, Frye RL, Bypass Angioplasty Revascularization Investigation (BARI) Investigators. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation. J Thorac Cardiovasc Surg 2007; 134: 38-46.
11. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997; 95:1366-1369.
12. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001; 104:2767-2771.
13. Mehilli J, Kastrati A, Schuhlen H, Dibra A, Dotzer F, von Beckerath N, et al., Intracoronary Stenting and Antithrombotic Regimen: Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics (ISAR-SWEET) Study Investigators. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation 2004; 110:3627-3635.
14. Biondi-ZoccaiG,Agostoni P,MorettiC,Meliga E, Sheiban I.Making reason of the recent meta-analytic confusion on the safety of drug-eluting stents. EuroIntervention 2007 - in press. Available at: http:// www.europcronline.com/ eurointervention/ahead-of-print/11-01/ (last accessed on 16 September 2007).
15. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356:989-997.
16. Valgimigli M, van Mieghem CA, Ong AT, Aoki F , Granillo GAR, McFadden EP, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH and T-SEARCH) registries. Circulation 2005; 111:1383-1389.
17. Park SJ, Kim YH, Lee BK, Lee SW, Cheol WL, Hong MK, et al. Sirolimuseluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 2005; 45:351-356.
18. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005; 111:791-795.
19. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006; 113:2542-2547.
20. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006; 47:864-870.
21. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006; 98:54-59.
22. Sanmartin M, Baz JA, Claro R, Asorey V, Duran D, Pradas G, Iniguez A. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol 2007; 100:970-973.
23. Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 2007; 116:745-754.